| 摘要 |
The main object of the present invention relates to novel crystalline form of Fosamprenavir Calcium designated as Form A. Another object of the present invention relates to a process for the preparation of Crystalline Form A of Fosamprenavir Calcium. Yet another object of the present invention relates to crystalline Form A of Fosamprenavir Calcium characterized by an PXRD diffraction having reflections at about 3.1�0.2, 4.4�0.2, 5.0�0.2, 6.3�0.2, 7.4�0.2, 8.0�0.2, 28. |
